Continuing Medical Education

Physicians
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum 6.25 of AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity

Pharmacists
Imedex, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This course (Universal Program Number 408-000-09-001-L01-P) has been approved for a maximum of 6.25 contact hours (0.625 CEUs). No partial credit will be awarded. Participants must complete an evaluation form and credit request form at the conclusion of the activity. Statements of credit will be issued electronically (PDF) and emailed within six weeks of the conclusion of the activity. There is a fee to participate in this activity.

Nursing

This program has been approved by the American Association of Critical Care Nurses (AACN) for 6.25 Contact Hours, CERP Category A, File number 00015390.

Who Should Attend

This educational activity is specifically designed for oncologists, hematologists and other healthcare professionals, including nurses and pharmacists, interested and/or involved in the care of patients with cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Discuss the most clinically relevant data presented at The 2009 Annual Oncology Meeting
• Describe the various approved treatment regimens or therapies for multiple solid tumors and hematologic malignancies
• Evaluate the new and emerging management strategies for the treatment of patients with multiple tumor types, focusing on the benefits and limitations of each
• Integrate the emerging data presented at The 2009 Annual Oncology Meeting into clinical practice

Pharmacy Learning Objectives

Upon completion of this activity, participants should be able to:

• Discuss the most clinically relevant data presented at The 2009 Annual Oncology Meeting
• Describe the various approved treatment regimens or therapies for multiple solid tumors and hematologic malignancies
• Evaluate the new and emerging management strategies for the treatment of patients with multiple tumor types, focusing on the benefits and limitations of each
• Integrate the emerging data presented at The 2009 Annual Oncology Meeting into clinical practice
• Incorporate knowledge of evolving treatment strategies into patient counseling practices to improve disease and supportive care management

Information Coming Soon

Registration Fees: $99.00

Pharmaceutical Industry Non-Supporters: $175.00

To Register: You may register online at www.imedex.com or by calling Imedex at +1 (678) 242 0906 or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.

Payment: To pre-register, registration and payment must be received no later than 5 business days before the conference start date. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 5 business days before the conference start date. The amount of registration fees remitted, minus a $25 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 5 business days before the conference start date.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Le Parker Meridien New York
July 11, 2009
119 West 56th Street
New York, New York 10019
+1 212 245 5000
Rate: $269 + 14.25% tax + $3.50 per room
Hotel Registration deadline: June 10, 2009
http://www.starwoodmeeting.com

For the convenience of attendees, a limited number of rooms have been reserved at the conference hotel along with the discounted rate and cut-off date as noted above plus tax. This rate is not guaranteed outside the conference dates.

To reserve your room please contact the hotel reservations department at the phone number above. To receive the group rate, callers must identify themselves as being with the 2009 Oncology Highlights Meeting. Reservation requests received after the hotel registration deadline as noted above may not be guaranteed the group rate.

The Registration and Information Desk will be staffed:
7:00 am – 4:30 pm

The following companies have provided an educational grant in support of this series:

Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.

The following companies are exhibitors at this conference:

Millennium
Pharmaceuticals, Inc.